Brian Lenz, EVP, CFO at ADMA BIOLOGICS, INC. (ADMA), sold 1,410,602 shares at $4.60 ($6.4M) on 2023-08-15, disclosed to the SEC on 2023-08-17.
Open-market sale of $6.4M ADMA by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.60 | 211,578 | $973K | 15.1% |
| 2 | $4.60 | 211,578 | $973K | 15.1% |
| 3 | $4.61 | 631,078 | $2.9M | 45.2% |
| 4 | $4.45 | 178,184 | $793K | 12.3% |
| 5 | $4.45 | 178,184 | $793K | 12.3% |
| Total | $4.57 avg | 1,410,602 |
| $6.4M |
| 100% |
| Filing → |
| ADMA | BUY | 2020-08-12 | $12K | — | Filing → |
| ADMA | BUY | 2020-02-11 | $25K | — | Filing → |
| ADMA | BUY | 2019-05-21 | $20K | — | Filing → |